Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mahendra, Suhardono"'
Autor:
Lianpan, Dai, Lidong, Gao, Lifeng, Tao, Sri R, Hadinegoro, Musabaev, Erkin, Zhifang, Ying, Peng, He, Rodman T, Girsang, Hugo, Vergara, Javed, Akram, Hindra I, Satari, Tanwir, Khaliq, Ume, Sughra, Ana P, Celi, Fangjun, Li, Yan, Li, Zhiwei, Jiang, Dilbar, Dalimova, Jaloliddin, Tuychiev, Shahlo, Turdikulova, Aamer, Ikram, Nancy, Flores Lastra, Fan, Ding, Mahendra, Suhardono, Eddy, Fadlyana, Jinghua, Yan, Zhongyu, Hu, Changgui, Li, Ibrokhim Y, Abdurakhmonov, George F, Gao, Zoraida, Vidal Perez
Publikováno v:
New England Journal of Medicine. 386:2097-2111
The ZF2001 vaccine, which contains a dimeric form of the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 and aluminum hydroxide as an adjuvant, was shown to be safe, with an acceptable side-effect profile, and immunogenic i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4810d0d68db3123ccb837738d804a5c
https://doi.org/10.1056/nejmoa2202261
https://doi.org/10.1056/nejmoa2202261
Autor:
Suresh Jadhav, Rajinder Kumar Suri, Ching-Chia Ting, Sonia Pagliusi, Li Meng, Patrick Tippoo, Sumana Khomvilai, Steven Gao, Akira Homma, Pan Hong Thai, Mahendra Suhardono, Vitoon Vonghangool, Ray Prasad
Publikováno v:
Vaccine. 34(31):3562-3567
The Developing Countries Vaccine Manufacturers Network (DCVMN) assembled high-profile leaders from global health organisations and vaccine manufactures for its 16th Annual General Meeting to work towards a common goal: providing quality vaccines for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3c7a5335614ebae9908fac2b33f00e9
Autor:
Mahima Datla, Mahendra Suhardono, Jan Hendriks, Suresh Jadhav, Weidan Huang, Yongzhong Gao, Sonia Pagliusi, Luciana C. C. Leite, Morena Makhoana, Yonglin Wu, Akira Homma, Gutla V.J.A. Harshavardhan, Alireza Gholami
Publikováno v:
Vaccine. 31:3111-3115
At the annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) members renewed their engagement and cooperative spirit in pursuing the mission of increasing the quality and availability of affordable vaccines for all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14d8ce04990de9aefe776c48733fe124
https://doi.org/10.1016/j.vaccine.2013.04.082
https://doi.org/10.1016/j.vaccine.2013.04.082
Autor:
Akira Homma, Mahendra Suhardono, Mahima Datla, Sonia Pagliusi, Gutla V.J.A. Harshavardhan, Morena Makhoana, Luciana C. C. Leite, Suresh Jadhav, Yongzhong Gao
Publikováno v:
Vaccine. 31:B176-B183
The Developing Countries Vaccine Manufacturers Network (DCVMN) is a unique model of a public and private international alliance. It assembles governmental and private organizations to work toward a common goal of manufacturing and supplying high-qual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4639b600b2c2ed74903e6163bcf766ee
https://doi.org/10.1016/j.vaccine.2012.11.060
https://doi.org/10.1016/j.vaccine.2012.11.060
Autor:
Livia Brunner, Otto de Boer, Michael K. O’Hara, Chuong Huynh, Nicolas Collin, Mahendra Suhardono, Bambang Heriyanto, Roland Ventura
Publikováno v:
Vaccine. 31:1641-1645
With the current enzootic circulation of highly pathogenic avian influenza viruses, the ability to increase global pandemic influenza vaccine production capacity is of paramount importance. This has been highlighted by, and is one of the main pillars
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aef9b7be0aa0cc70537a7abaaeaa2f92
https://doi.org/10.1016/j.vaccine.2012.07.074
https://doi.org/10.1016/j.vaccine.2012.07.074
Autor:
Sonia Pagliusi, Ching-Chia Ting, Fernando Lobos, Mahima Datla, Steven Gao, Akira Homma, Li Meng, Mahendra Suhardono, Rajinder Suri, Patrick Tippoo
Publikováno v:
Vaccine
The Developing Countries Vaccine Manufacturers' Network (DCVMN) gathered leaders in immunization programs, vaccine manufacturing, representatives of the Argentinean Health Authorities and Pan American Health Organization, among other global health st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::628304f1273fa881a5af0fe31be9f9ff
https://pubmed.ncbi.nlm.nih.gov/28237501
https://pubmed.ncbi.nlm.nih.gov/28237501
Publikováno v:
Vaccine. 29:A22-A25
In Indonesia, avian influenza A(H5N1) virus started to spread in humans in June 2005, with an alarming case-fatality rate of more than 80%. Considering that global influenza vaccine production capacity would barely have covered 10% of the world's pan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dc2f4e1d0deb573cf419a906bbfe77a